| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(19)32982-4 |
| P698 | PubMed publication ID | 31839279 |
| P50 | author | Pär-Daniel Sundvall | Q62022487 |
| Sławomir Chlabicz | Q91989913 | ||
| Menno D de Jong | Q92336899 | ||
| Peter Openshaw | Q18387924 | ||
| Samuel Coenen | Q30505135 | ||
| Margareta Ieven | Q37067470 | ||
| Lars Bjerrum | Q40381496 | ||
| Nick A Francis | Q41581137 | ||
| Annelies Colliers | Q57570430 | ||
| P2093 | author name string | Dominik Glinz | |
| Rune Aabenhus | |||
| Heiner C Bucher | |||
| Paul Little | |||
| Andrew W Murphy | |||
| An De Sutter | |||
| Roger J Lewis | |||
| Christos Lionis | |||
| Herman Goossens | |||
| Christopher C Butler | |||
| Jason T Connor | |||
| Emily Bongard | |||
| Bohumil Seifert | |||
| Theo J Verheij | |||
| Carl Llor | |||
| Maciek Godycki-Cwirko | |||
| Morten Lindbæk | |||
| Benjamin R Saville | |||
| Alike W van der Velden | |||
| Jane Holmes | |||
| Veerle Matheeussen | |||
| Nicolay Jonassen Harbin | |||
| Bernadett Kovács | |||
| Pia Touboul Lundgren | |||
| Johanna Cook | |||
| Ruta Radzeviciene Jurgute | |||
| P2860 | cites work | Neuraminidase inhibitors for influenza | Q87840530 |
| Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis | Q30353138 | ||
| Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. | Q30361230 | ||
| Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza | Q30389366 | ||
| Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials | Q34033665 | ||
| Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials | Q34460803 | ||
| A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers | Q34974411 | ||
| Age and sex as moderators of the placebo response – an evaluation of systematic reviews and meta-analyses across medicine | Q35513153 | ||
| An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project | Q36570348 | ||
| Pragmatic trials: defining questions, choosing comparators, allocating treatments | Q38685518 | ||
| Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial | Q40152886 | ||
| Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group | Q40625504 | ||
| European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe | Q44410690 | ||
| Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials | Q47397356 | ||
| Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. | Q48719424 | ||
| Aetiology of Lower Respiratory Tract Infection in Adults in Primary Care: A prospective Study in 11 European Countries. | Q49970495 | ||
| A Randomized Study Evaluating the Effectiveness of Oseltamivir Initiated at the Time of Hospital Admission in Adults Hospitalized With Influenza-Associated Lower Respiratory Tract Infections. | Q54180498 | ||
| Pragmatic Trials. | Q54484116 | ||
| Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC E): the ALIC E protocol | Q57094242 | ||
| Canadian Acute Respiratory Illness and Flu Scale (CARIFS) | Q57794043 | ||
| Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents | Q59353237 | ||
| P433 | issue | 10217 | |
| P921 | main subject | oseltamivir | Q211509 |
| P304 | page(s) | 42-52 | |
| P577 | publication date | 2019-12-12 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial | |
| P478 | volume | 395 |
| Q100407560 | Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial |
| Q90330879 | Performance and ease of use of a molecular point-of-care test for influenza A/B and RSV in patients presenting to primary care |
Search more.